Know Cancer

or
forgot password
  • cancer clinical trials in portland, OR

  • Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Knight Cancer Institute at Oregon Health and Science University

    Trial Locations
    Knight Cancer Institute at Oregon Health and Science University
    Legacy Emanuel Children's Hospital
    Leukemia
    Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
    Oregon Health & Science University
    Portland, Oregon 97201
    Hemangioma, Infant
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    CCOP - Columbia River Oncology Program

    Trial Locations
    CCOP - Columbia River Oncology Program
    Legacy Emanuel Hospital and Health Center and Children's Hospital
    Kaiser Permanente Health Care - Portland
    Providence Cancer Center at Providence Portland Medical Center
    Providence St. Vincent Medical Center
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Colorectal Cancer
    Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Childhood Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
    Knight Cancer Institute at Oregon Health and Science University
    Portland, Oregon 97239-3098
    Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Childhood Solid Tumor, Protocol Specific
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Oregon Health and Science University

    Trial Locations
    Oregon Health and Science University
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Providence Saint Vincent Medical Center

    Trial Locations
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Natural History Study of SCID Disorders
    Oregon Health and Science University
    Portland, Oregon 97201
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Legacy Emanuel Children's Hospital

    Trial Locations
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Oregon Health and Science University
    Portland, Oregon 97201
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
    Oregon Health & Science University

    Trial Locations
    Oregon Health & Science University
    Oregon Dermatology and Research Center
    Orgeon Med Research Center, PC
    Plaque Psoriasis
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Legacy Good Samaritan Hospital & Comprehensive Cancer Center
    Portland, Oregon 97210
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Kaiser Permanente
    Legacy Good Samaritan Hospital and Medical Center
    Northwest Cancer Specialists-Rose Quarter Cancer Center
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Study of PX-866 and Docetaxel in Solid Tumors
    Northwest Cancer Specialists

    Trial Locations
    Northwest Cancer Specialists
    Kaiser Permanante Northwest
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Legacy Emanuel Children's Hospital

    Trial Locations
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Legacy Emanuel Hospital and Health Center

    Trial Locations
    Legacy Emanuel Hospital and Health Center
    Legacy Emanuel Children's Hospital
    Oregon Health and Science University
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Providence Cancer Center at Providence Portland Medical Center
    Portland, Oregon 97213-2967
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Sulforaphane in Treating Patients With Recurrent Prostate Cancer
    OHSU Knight Cancer Institute
    Portland, Oregon 97239
    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Providence Portland Medical Center

    Trial Locations
    Providence Portland Medical Center
    Providence Saint Vincent Medical Center
    Columbia River Oncology Program
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Oregon Health and Science University
    Portland, Oregon 97201
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
    Oregon Health and Science University
    Portland, Oregon 97201
    Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Juvenile Myelomonocytic Leukemia, Mast Cell Leukemia, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    Safety and Efficacy of PCI-32765 in Subjects With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
    Oregon Health & Science University
    Portland, Oregon 97201
    Mantle Cell Lymphoma
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    Oregon Health and Science University
    Portland, Oregon 97201
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
    Portland VA Medical Center, Portland, OR
    Portland, Oregon 97201
    Colorectal Cancer